New Mexico federal court denied AbbVie's motion for a preliminary injunction against H.B. 78, a state law restricting manufacturer data demands in the 340B program. The ruling rejects AbbVie's federal preemption arguments, allowing the state law to proceed. Financial impact is limited near-term: the law is narrow (New Mexico only), the federal Rebate Program is not yet operative, and the ruling is a preliminary denial, not a final merits decision. The stock has historically absorbed similar neutral rulings without sustained downside.
ABBV drugs
ABBV drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 15 $261.43entry
- T+1 · 2mo ago −0.20%α +0.24% · $260.91
- T+5 · 8w ago +0.82%α −1.54% · $263.59
- T+20 · 5w ago +4.30%α +1.33% · $272.69
- T+44 · todayOpen
- T+60 · in 22d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
New Mexico federal court denied AbbVie's motion for a preliminary injunction against H.B. 78, a state law restricting manufacturer data demands in the 340B program. The ruling rejects AbbVie's federal preemption arguments, allowing the state law to proceed. Financial impact is limited near-term: the law is narrow (New Mexico only), the federal Rebate Program is not yet operative, and the ruling is a preliminary denial, not a final merits decision. The stock has historically absorbed similar neutral rulings without sustained downside.
Financial Impact
Not specified
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-266eea10b1-ABBV |
Track record
22 reports on ABBV
7 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +27.21% at T+60 after the Apr 29, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $293.89 Now $294.55 +0.22% settles Dec 9
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $286.00 Now $294.55 +2.99% settles Dec 2
- Oct 30, 202617d ago 8-K Bullish 6/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
- Oct 29, 202619d ago Court Ruling Bullish 7/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
- Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $282.68 to $294.55 Now $294.55 +4.20% ▲ +4.20% +7.66% vs SPY
- Oct 15, 20264w ago 8-K Neutral 2/10 Entry $285.42 to $295.03 Now $294.55 +3.20% ▲ +3.37% +4.53% vs SPY
- Oct 5, 20266w ago 8-K Neutral 4/10 Entry $265.06 to $289.60 Now $294.55 +11.12% ▲ +9.26% +12.16% vs SPY
- Sep 28, 20267w ago Court Ruling Neutral 2/10 Entry $263.29 to $286.39 Now $294.55 +11.87% ▲ +8.77% +8.06% vs SPY
- Sep 14, 20269w ago Court Ruling Neutral Not scored Viewing Entry $261.43 to $272.69 Now $294.55 +12.67% ▲ +4.30% +1.33% vs SPY
- Sep 3, 202610w ago 8-K Neutral 4/10 Entry $260.21 to $262.82 Now $294.55 +13.20% ▲ +1.00% +2.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers